糖尿病发病与肝脏及其临床处理
摘要
2型糖尿病的主要病理生理机制包括肌肉、肝脏中存在胰岛素抵抗和13细胞功能受损，引起肝糖输出增加、肌肉对葡萄糖的摄取降低和胰岛素分泌量的减少，被称为糖尿病的“三重奏”。事实上，在2型糖尿病的病程中B细胞功能衰退出现时间之早和程度之严重远远超出人们的想象。当患者血糖处于糖耐量减低（IGT）水平的高端时，
出处
《实用糖尿病杂志》
2012年第6期12-14,共3页
Journal of Practical Diabetology
参考文献16
-
1DeFronzo RA. From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus. Diabetes 2009; 58:773 -795.
-
2Bergman RN, Finegood DT, Kahn SE. The evolution of beta- cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest 2002 ; 32:35 - 45.
-
3DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 2004; 88:787 -835.
-
4Matsuda M, DeFronzo RA, Glass-L, et al. Glucagon dose response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals. Metabolism 2002; 51:1111 - 1119.
-
5Gastaldelli A, Baldi S, Pettiti M, et al. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 2000; 49 : 1367 - 1373.
-
6Clore JN, Stillman J, Sugerman H. Glucose - 6 - phosphatase flux in vitro is increased in type 2 diabetes. Diabetes 2000 ; 49: 969 - 974.
-
7Morino K, Petersen KF, Dufour S, et al. Reduced mitochondrial density and increased IRS - 1 serine phosphorylation in muscle of insulin - resistant offspring of type 2 diabetic parents. J Clin Invest 2005 ;115:3587 - 3593.
-
8Cusi K, Maezono K, Osman A, et al. Insulin resistance differentially affects the PI 3 - kinase and MAP kinase - mediated signaling.in human muscle. J Clin Invest 2000; 105:311 -320.
-
9DeFronzo RA & Tripathy D. Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes. Diabetes Care 2009 ; 32(Suppl 2) :s157 - s163.
-
10DeFronzo RA &Abdul - Ghani MA. Preservation of β - Cell Function: The Key to Diabetes Prevention. J Clin Endocrinol Metab 2011 ; 96:2354 - 2366.
-
1糖尿病患者不要敲响“死亡三重奏”[J].糖尿病天地,2015,0(12):28-28.
-
2魏华,毛睿睿,陈红霞,冯维斌.2型糖尿病胰岛素抵抗的中医药研究进展[J].光明中医,2004,19(6):37-39. 被引量：6
-
3丁慧,袁迎霞.吡格列酮对高血压肥胖患者的降压作用[J].河北医药,2013,35(20):3127-3128.
-
4黄国良,张静雯,陈林.三足鼎立的三重奏—糖尿病发病与肝脏组织及其临床处理[J].实用糖尿病杂志,2012,8(5):10-11. 被引量：1
-
5徐明彤.新型口服降糖药及口服降糖药新剂型[J].药品评价,2008,5(4):160-163. 被引量：12
-
6董飞侠.糖尿病弹响机体损害“三重奏”[J].家庭中医药,2006,13(1):25-26.
-
7王欣,刘芳,贾伟平.一种新发现的脂肪细胞因子——内脂素[J].上海医学,2007,30(3):221-222. 被引量：15
-
8餐前胰岛素注射可灵活一些[J].糖尿病天地,2011(6):15-15.
-
9顾楠,郭晓蕙.危重糖尿病患者的强化血糖治疗[J].中国医学前沿杂志（电子版）,2012,4(3):15-18.
-
10项守奎(综述),朱大龙(审校.α细胞、胰高血糖素与2型糖尿病[J].医学研究生学报,2010,23(4):440-443. 被引量：11
